Literature DB >> 21607764

[Detection and characterization of liver metastases].

H-P Weskott1.   

Abstract

Since the advent of second generation ultrasound (US) contrast agents, ultrasound has caught up with other imaging modalities for the detection and characterization of liver metastases and as a result of its high temporal and spatial resolution it can in some cases even be superior to computed tomography (CT) and magnetic resonance imaging (MRI). Many studies have demonstrated a sensitivity and specificity of over 90%. Due to its high temporal resolution contrast-enhanced US (CEUS) is capable of detecting even a very short duration of hyper-enhancement during the arterial phase. Radiation protection and lack of adverse effects on renal or thyroid function are additional arguments why CEUS should be recommended as the first imaging modality in the evaluation of hepatic metastases in cases of favorable scanning conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21607764     DOI: 10.1007/s00117-010-2100-z

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  23 in total

1.  Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.

Authors:  Emilio Quaia; Fabrizio Calliada; Michele Bertolotto; Sandro Rossi; Lorena Garioni; Laura Rosa; Roberto Pozzi-Mucelli
Journal:  Radiology       Date:  2004-08       Impact factor: 11.105

2.  Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?

Authors:  Edward Leen; Piercarlo Ceccotti; Susan J Moug; Paul Glen; John MacQuarrie; Wilson J Angerson; Thomas Albrecht; Joachim Hohmann; Anja Oldenburg; Jorg Peter Ritz; Paul G Horgan
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings.

Authors:  Linda Chami; Nathalie Lassau; David Malka; Michel Ducreux; Sophie Bidault; Alain Roche; Dominique Elias
Journal:  AJR Am J Roentgenol       Date:  2008-03       Impact factor: 3.959

4.  Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008.

Authors:  M Claudon; D Cosgrove; T Albrecht; L Bolondi; M Bosio; F Calliada; J-M Correas; K Darge; C Dietrich; M D'Onofrio; D H Evans; C Filice; L Greiner; K Jäger; N de Jong; E Leen; R Lencioni; D Lindsell; A Martegani; S Meairs; C Nolsøe; F Piscaglia; P Ricci; G Seidel; B Skjoldbye; L Solbiati; L Thorelius; F Tranquart; H P Weskott; T Whittingham
Journal:  Ultraschall Med       Date:  2008-02       Impact factor: 6.548

5.  Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy.

Authors:  R Konopke; S Kersting; H Bergert; A Bloomenthal; J Gastmeier; H D Saeger; A Bunk
Journal:  Int J Colorectal Dis       Date:  2006-05-30       Impact factor: 2.571

6.  Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

Authors:  Stéphane Benoist; Antoine Brouquet; Christophe Penna; Catherine Julié; Mostafa El Hajjam; Sophie Chagnon; Emmanuel Mitry; Philippe Rougier; Bernard Nordlinger
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

7.  Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy.

Authors:  R Konopke; A Bunk; S Kersting
Journal:  Ultraschall Med       Date:  2008-10-02       Impact factor: 6.548

8.  Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial).

Authors:  D Strobel; K Seitz; W Blank; A Schuler; C Dietrich; A von Herbay; M Friedrich-Rust; G Kunze; D Becker; U Will; W Kratzer; F W Albert; C Pachmann; K Dirks; H Strunk; C Greis; T Bernatik
Journal:  Ultraschall Med       Date:  2008-10       Impact factor: 6.548

9.  Inadequacy of ultrasonography for monitoring response to treatment of liver metastases.

Authors:  A Giovagnoni; A Piga; G Argalia; G M Giuseppetti; P Ercolani; R Cellerino
Journal:  J Clin Oncol       Date:  1993-12       Impact factor: 44.544

10.  Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer.

Authors:  Fabio Piscaglia; Francesco Corradi; Mikaela Mancini; Francesco Giangregorio; Stefano Tamberi; Giampaolo Ugolini; Bruno Cola; Alberto Bazzocchi; Roberto Righini; Patrizia Pini; Fabio Fornari; Luigi Bolondi
Journal:  BMC Cancer       Date:  2007-09-03       Impact factor: 4.430

View more
  1 in total

Review 1.  [Latest developments in ultrasound of the liver].

Authors:  D-A Clevert; A Helck; P M Paprottka; F Schwarz; M F Reiser
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.